Upcyte Technologies

Developing quasi (human) primary cell products to develop cost-effective cell based assays

placeHamburg, Hamburg, Germany calendar_todayFounded 2015 language upcyte.com

Registered entities

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon